AFPHM Monthly Webinar
12 Apr 2021 at 12:30 PM to 1:30 PM
Measuring the public health impact of vaccines – from principles to practice
There a number of factors to consider in measuring the public health impact of vaccines, with considerable variation by vaccine type.
Initially, randomised clinical trials measure vaccine efficacy and safety in the short term against very specific endpoints, whereas following population level use, longer-term impacts in population groups not eligible for vaccination and against less specific syndromic end points are often of greater interest and can change how vaccines are used. We are beginning to see this play out with respect to COVID-19.
About the speaker
Professor Peter McIntyre has clinical qualifications as a paediatrician specialising in infectious diseases and as a public health physician. His research has focused on measuring burden of vaccine-preventable diseases and impact and effectiveness of vaccines.
He was Director of the Australian National Centre for Immunisation Research 2004 to 2017. Since 2019, he's been a Professor at the University of Otago and a member of the Strategic Advisory Group of Experts for immunisation of the World Health Organisation.